Ltd. to Fund Immunotherapy for Treatment of Cancer in China
Home  »  Community News  »  Ltd. to Fund Immunotherapy for Treatment of Cancer in China
Mar
23
ragupathyrenganathan
Quest PharmaTech’s Subsidiary, OncoQuest, Signs Agreement with Shenzhen Hepalink Pharmaceutical Co., Ltd. to Fund Immunotherapy for Treatment of Cancer in China
Pharma News
0
, , ,